Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kallunk Oxide in HIV/AIDS
NCT00276991Phase 2Terminated
- Sponsor
- Traditional Alternative Medicine Research
- Start
- Nov 2007
- Primary completion
- Oct 2009
- Countries
- 1
01
Overview
A Phase 2 trial of Kallunk oxide in human immunodeficiency virus infection (HIV), sponsored by Traditional Alternative Medicine Research. Started Nov 2007; status: terminated.
02
Drugs
Kallunk oxide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00276991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276991.